USPTO director steps into Sun Pharma’s PTAB-ITC clash - Life Sciences IP Review

Affected tickers

Per-ticker News Sentiment Indicator

• ITCregulatory · negative · med

  The USPTO director's intervention in the legal dispute creates regulatory uncertainty regarding the company's intellectual property rights.

Article body